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Omega-3 polyunsaturated fatty acids (n-3 PUFA) inhibit ultraviolet B (UVB)-induced inﬂammation and other in-
ﬂammatory states, in vivo. We examined whether this may be mediated by modulation of interleukin (IL)-8, a
chemokine pivotal to skin inﬂammation induced by UVB, in epidermal and dermal cells. We also explored the ability
of n-3 PUFA to protect against tumor necrosis factor (TNF)-a induction of IL-8, and assessed relative potencies of
the principal dietary n-3 PUFA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Pre-supplemen-
tation, both HaCaT keratinocyte and CCD922SK ﬁbroblast cell lines showed dose–responses for UVB-induced IL-8
release (po0.001), assessed 48 h post-irradiation. Cells were supplemented with X90% puriﬁed EPA, DHA, oleic
acid (OA) or vehicle control, for 4.5 d. EPA and DHA supplements were bioavailable to keratinocytes and ﬁbro-
blasts. In keratinocytes, EPA and DHA were shown to reduce basal secretion of IL-8 by 66% and 63%, respectively
(po0.05), and UVB-induced levels by 66% and 65% at 48 h after 100 mJ per cm2, respectively, (po0.01). A similar
pattern occurred in ﬁbroblasts, whereas OA had no inﬂuence on IL-8 release in either cell line. In addition, TNF-a-
induced IL-8 secretion by keratinocytes was reduced by 54% and 42%, respectively, by EPA and DHA (po0.001).
Hence both n-3 PUFA inhibit production of UVB- and TNF-a-induced IL-8 in skin cells; this may be important in the
photoprotective and other anti-inﬂammatory effects conferred by these agents.
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Ultraviolet radiation (UVR) causes a range of acute and
chronic effects on the skin, including sunburn, immunosup-
pression, carcinogenesis, and photoaging. Both ultraviolet-
A (UVA) and ultraviolet-B (UVB) have deleterious effects,
although UVB is the most potent waveband with respect to
the inflammatory (sunburn) response and certain skin can-
cers (de Gruijl and Van der Leun, 1994). Systemic agents
could potentially play a role in photoprotection; a safe di-
etary supplement that could reduce the damaging effects of
UVR on the skin might be beneficial both to susceptible
individuals and the population generally. It has been report-
ed from studies in animals (Orengo et al, 1989) and humans
(Orengo et al, 1992; Rhodes et al, 1994, 2003) that fish oils,
rich in omega-3 polyunsaturated fatty acids (n-3 PUFA),
possess anti-inflammatory properties in UVB-exposed skin.
The underlying mechanisms, including effects on pro-in-
flammatory mediators, are unclear.
Omega-3 PUFA are reported to reduce inflammation in a
range of disorders including cardiovascular disease, ulcer-
ative colitis, rheumatoid arthritis, and psoriasis (Kremer
et al, 1990; Blok et al, 1996; Mayser et al, 2002). Potential
mechanisms are modulation of pro-inflammatory cytokines
(Calder, 1997; Harbige, 1998) and n-6 eicosanoids (Ziboh,
1989). Omega-3 PUFA and n-6 PUFA compete for metab-
olism to eicosanoids, and it has been shown that dietary n-3
PUFA supplementation is associated with their increased
incorporation into skin and reduced basal and UVB-induced
skin prostaglandin E2 (PGE2) levels (Ziboh, 1989; Rhodes
et al, 1995). Omega-3 PUFA supplementation has also been
shown to reduce secretion of pro-inflammatory cytokines
tumor necrosis factor (TNF)-a and interleukin (IL)-1b in cir-
culating monocytes (Endres et al, 1989; Blok et al, 1996).
Recently, an in vitro model of UVB-induced inflammation
revealed conflicting effects of the purified n-3 PUFA,
eicosapentaenoic acid (EPA), on the expression of the
cytokines examined (Pupe et al, 2002). Since UVB radiation
initiates a complex cytokine network in the skin, with in-
duction of several pro-inflammatory cytokines (Schwarz and
Luger, 1989), the potential influence of n-3 PUFA on other
key mediators requires examination.
IL-8, a pro-inflammatory and chemotactic cytokine be-
longing to the C–X–C sub-family of chemokines, is impor-
tant in the mediation of UVB-induced inflammation. It is
upregulated in human keratinocytes following UVB-irradia-
tion in vitro (Kondo et al, 1993; Stein et al, 1997; Pernet et al,
1999) and in vivo (Strickland et al, 1997) and notably pro-
motes a neutrophilic infiltrate in human skin (Cooper et al,
1993). In addition to chemotactic effects on polymorpho-
nuclear cells, T lymphocytes and keratinocytes (Matsushima
Abbreviations: AA, arachidonic acid; DHA, docosahexaenoic acid;
EPA, eicosapentaenoic acid; FA, fatty acids; FAME, fatty acid me-
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and Oppenheim, 1989; Colditz and Watson, 1992; Michel
et al, 1992), IL-8 induces the respiratory burst and degran-
ulation in neutrophils, and the release of leukotriene B4 and
histamine in basophils (Oppenheim et al, 1991; Koch et al,
1992). The release of degradative lysosomal enzymes and
oxidative products are responsible for the tissue inflamma-
tion and cytotoxicity associated with neutrophil infiltration.
Although the primary source of IL-8 is monocytes, it is also
produced by macrophages, keratinocytes, fibroblasts, and
endothelial cells. Since UVB can penetrate to the upper
dermis (Everett et al, 1966; Young et al, 1998), it is con-
ceivable that UVB might directly stimulate IL-8 production in
dermal as well as epidermal cells, in addition to indirect
stimulation through cytokine induction. Due to their loca-
tion, production of IL-8 by fibroblasts may be important for
communication with dermal endothelial cells, enhancing
neutrophil migration into the dermis after UVB exposure.
TNF-a, which can be induced by UVB and a range of other
inflammatory stimuli, is also capable of inducing IL-8 se-
cretion by skin cells. TNF-a mediates several inflammatory
activities including sunburn cell formation, Langerhans cell
migration and autocrine stimulation of further pro-inflam-
matory cytokines (Kock et al, 1990).
The aims of this study were to examine the effects of the
2 principal dietary n-3 PUFA, EPA and docosahexaenoic
acid (DHA), on IL-8 secretion by basal and UVB-exposed
skin cells. UVB-induced IL-8 dose–responses were com-
pared in keratinocyte and fibroblast cell lines, and bioavail-
ability of the FA was confirmed following supplementation.
Additionally, the effects of the n-3 PUFA on TNF-a-induced
IL-8 secretion in keratinocytes were examined, to assess
the potential for protection against a broader range of in-
flammatory stimuli.
Results
UVB induced a dose-related IL-8 release by keratin-
ocytes and ﬁbroblasts, with a smaller-fold increase in
ﬁbroblasts Doses of UVB increasing from 25 to 100 mJ per
cm2 produced an IL-8 dose–response in keratinocytes at 48
h, IL-8 levels in the culture medium increasing approx-
imately 30-fold from 297.1  56.7 in unexposed cells to
8.7  103  599 pg per 106 cells after 100 mJ per cm2 UVB
(po0.001, Fig 1a). Fibroblasts showed a higher basal IL-8
secretion than keratinocytes (Fig 1b). There was a dose-
related production of IL-8 in response to UVB, with a small-
er-fold increase in IL-8 at all UV doses in comparison with
keratinocytes. At 48 h after 100 mJ per cm2 UVB, basal IL-8
levels increased 3-fold, from 64.1  2.4 to 185.2  15 ng
per 106 cells (po0.001).
UVB induced significant increases in IL-8 secretion at
24, 48, and 72 h post-exposure in keratinocytes, and at
24 and 48 h in ﬁbroblasts In a time-course experiment
following 100 mJ per cm2 UVB, significant induction of IL-8
was seen at 24, 48, and 72 h in keratinocytes, with optimal
induction at 48 h. In fibroblasts, 100 mJ per cm2 UVB sig-
nificantly increased IL-8 production at 24 and 48 h (Fig 2b).
At 72 h, rises in IL-8 occurred in untreated as well as UV-
exposed cells; the reason is unknown, but this might be
attributable to cellular stress occurring during the longer
culture period. The 48 h post-UVB time point was selected
for use in further experiments in both cell lines.
EPA and DHA were incorporated into keratinocytes and
ﬁbroblasts Oleic acid (OA)-supplemented keratinocytes
did not show a significant increase in OA content; by con-
trast EPA-supplemented keratinocytes showed a higher
percentage of EPA, rising from 0 pre-supplementation to
3.4%  0.3% total FA (po0.001), and DHA supplementa-
tion produced an increased content of EPA and DHA, rising
from 0 to 2.4%  0.4% and 6.3%  1.7%, respectively,
po0.001 (Table I). This increased content of EPA seen dur-
ing DHA supplementation is explained by retroconversion of
DHA to EPA (Vidgren et al, 1997).
In EPA-supplemented keratinocytes, exposure to UVB
significantly decreased the content of EPA, from
3.4%  0.3% to 2%  0.1% total FA (po0.001), in com-
parison with unirradiated cells. OA was shown to be readily
released from cell lipids following 100 mJ per cm2 UVB: in
tetrahydrofuran (THF)/fetal calf serum (FCS) supplemented
keratinocytes the proportion of OA decreased from
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UVB-induced IL-8 dose-response in keratinocytes and fibroblasts.
The effect of ultraviolet-B (UVB) dose on interleukin (IL)-8 production by
(a) HaCaT keratinocytes (n¼5–6) and (b) CCD922SK fibroblasts (n¼ 5).
IL-8 production is UVB-dose related in both cell lines. po0.01,
po0.001 compared with unexposed cells.
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as in OA-supplemented cells OA decreased from
46.7%  3.4% to 40.1%  1.9% (po0.01).
When compared with keratinocytes, fibroblast FA com-
position generally consisted of higher levels of longer chain
FA, such as the 20-carbon FA, and less OA. DHA-supple-
mented fibroblasts showed increased incorporation of DHA,
which rose from 3.2%  1.0% to 17.4%  0.2% total FA
(po0.001), whereas EPA-supplemented fibroblasts showed
an approximate 2-fold increase in EPA incorporation, from
5.7%  1.6% to 11.1%  2%, although this did not reach
statistical significance (Table II). Again, there was no effec-
tive incorporation of OA into cell membranes.
EPA and DHA reduced basal IL-8 secretion by keratin-
ocytes The basal and UVB-induced levels of IL-8 produced
by the FCS/THF FA-supplemented cells were higher than
previously observed; the reason for this is uncertain but is
presumed to result from the longer cell culture period. EPA-
and DHA-treated cells produced significantly less basal IL-8
than THF/FCS-treated control cells, reducing levels from
7279  1089 to 2506  666 and 2717  261 IL-8 pg/ng
protein, respectively (po0.05) (Fig 3). EPA and DHA had
similar potencies regarding inhibition of IL-8 release (66%
and 63% reduction, respectively).
EPA and DHA reduced UVB-induced IL-8 secretion by
keratinocytes The effects of supplemental FA on IL-8 pro-
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Time-course of UVB-induced IL-8 response in keratinocytes and
fibroblasts. Time-course of interleukin (IL)-8 production after a single
dose of 100 mJ per cm2 ultraviolet-B (UVB), in (a) HaCaT keratinocytes
(n¼ 5–6) and (b) CCD922SK fibroblasts (n¼ 4–6). po0.05, po0.01
compared with unexposed cells; , unirradiated and , irradiated cells.
Table I. The effect of supplementary fatty acids, OA, EPA, and
DHA, compared with THF/FCS vehicle control, on fatty acid
composition of HaCaT keratinocytes, both unirradiated and
following exposure to 100 mJ per cm2 of UVB
% FAME
Treatments
T/F OA EPA DHA
0 mJ per cm2
18-1n-9 (OA) 45.2  1.9 46.7  3.4 40.1  0.8 33.6  1.4b
20-5n-3 (EPA) 0 0.7  0.3 3.4  0.3b 2.4  0.4b
22-6n-3 (DHA) 0 0 0 6.3  1.7b
100 mJ per cm2
18-1n-9 (OA) 37.6  1.6c 40.1  1.9c 30.1  0.5a,d 30.2  0.8a
20-5n-3 (EPA) 0.9  0.4c 0.4  0.1 2.0  0.1a,d 2.7  0.4b
22-6n-3 (DHA) 0.6  0.5 0 0.1  0.1 5.4  1.6b
Data are presented as mean  SEM (n¼ 4).
apo0.01, comparing supplemented groups with the THF/FCS (T/F)
control group.
bpo0.001, comparing supplemented groups with the THF/FCS (T/F)
control group.
cpo0.01, comparing UVB-irradiated cells to non-irradiated cells.
dpo0.001, comparing UVB-irradiated cells to non-irradiated cells.
Values are % total FAME.
OA, oleic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic
acid; THF, tetrahydrofuran; FCS, fetal calf serum; UVB, ultraviolet-B;
FAME, fatty acid methyl esters.
Table II. The effect of supplementary fatty acids, OA, EPA, and
DHA, compared with THF/FCS vehicle control, on fatty acid
composition of CCD922SK ﬁbroblasts, unexposed and after
100 mJ per cm2 of UVB
% FAME
Treatments
T/F OA EPA DHA
0 mJ per cm2
18-1n-9 (OA) 22  2.4 25.2  8.7 29.2  2.9 22.8  1.6
20-5n-3 (EPA) 5.7  1.6 7.3  2.4 11.1  2 7.1  1
22-6n-3 (DHA) 3.2  1 1.8  0.4 0a 17.4  0.2b
100 mJ per cm2
18-1n-9 (OA) 27.9  4.5 10.4  3.7b,c 25.5  1.8 19.1  4
20-5n-3 (EPA) 7.3  0.3 17.6  3.2b,c 10.3  0.8 7.9  1.9
22-6n-3 (DHA) 4.3  0.8 3.6  1.7 0b 14.8  1.2b,c
Data are presented as mean  SEM (n¼ 3–6).
apo0.01, comparing supplemented groups with the T/F (THF/FCS)
control group.
bpo0.001, comparing supplemented groups with the T/F (THF/FCS)
control group.
cpo0.01 comparing UVB-irradiated cells to non-irradiated cells.
Values given are % total FAME.
OA, oleic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic
acid; THF, tetrahydrofuran; FCS, fetal calf serum; UVB, ultraviolet-B;
FAME, fatty acid methyl esters.
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irradiation and exposure to 100 mJ per cm2 UVB (Fig 3).
UVB significantly induced IL-8 in the THF/FCS and OA
control groups. EPA and DHA reduced UVB-induced IL-8
production compared with THF/FCS-treated cells, from
37,113  1089 to 12,462  5616 IL-8 pg/ng protein
(po0.05) and 12,842  3627 IL-8 pg/ng protein (po0.01),
respectively. EPA and DHA had similar potencies regarding
inhibition of IL-8 release in UVB-exposed cells (66% and
65%, respectively).
EPA and DHA showed a trend for reduction of UVB-
induced IL-8 secretion by ﬁbroblasts The basal and
UVB-induced IL-8 levels of the n-3 PUFA supplemented
cells were not significantly different from the THF/FCS-
treated control cells. After EPA and DHA there was, how-
ever, a trend for reduction in UVB-induced IL-8, whereas
OA-treated cells produced a similar, if not greater, level
of IL-8 post-irradiation compared with the THF/FCS group
(Fig 4).
EPA and DHA reduced TNF-a-induced IL-8 secretion by
keratinocytes In order to explore the broader anti-inflam-
matory properties of the n-3 PUFA, and to provide further
confirmation that EPA and DHA were inhibiting IL-8 release
in a process independent of direct absorption of UVB by FA,
TNF-a was used to induce IL-8 instead of UVB. Following
2 ng per mL of TNF-a IL-8 increased from a baseline of
4.1  3.6 to 3474.4  440 pg/ng protein (po0.001), where-
as 20 ng per mL of TNF-a increased IL-8 levels to
6694.8  618.7 pg/ng protein (po0.001), a 1600-fold rise.
The latter dose was chosen for the supplementation exper-
iments. TNF-a-induced IL-8 secretion was reduced from
11,669  1692 pg/ng protein in vehicle control cells to
5405  594 by EPA (po0.001) and to 6740  1049 pg/ng
protein by DHA (po0.001), whereas IL-8 induction was not
significantly altered by OA (Fig 5).
Discussion
Reduction of UVB-induced IL-8 secretion by keratinocytes
demonstrates a potentially important mechanism for pro-
tection against UVB-induced skin inflammation by n-3
PUFA. Significant dose-related increases in IL-8 secretion
were seen following UVB irradiation, with reduction of basal
and UVB-induced levels by two-thirds with both EPA and
DHA. IL-8 is a key mediator of UVB-induced inflammation,
acting as a potent chemoattractant for neutrophils, which
then cause local tissue damage through release of toxic




















Effects of n-3 PUFA on basal and UVB-induced IL-8 in keratino-
cytes. The effect of eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA) on interleukin (IL)-8 production by HaCaT cells, in unex-
posed cells ( ) and at 48 h after 100 mJ per cm2 ultraviolet-B (UVB) ( )
(n¼ 4). Oleic acid (OA) and T/F (tetrahydrofuran (THF)/fetal calf serum
(FCS))-treated cells are the control groups. po0.05, po0.001
comparing irradiated with non-irradiated cells, þpo0.05, þ þpo0.01


















Effects of n-3 PUFA on basal and UVB-induced IL-8 in fibroblasts.
The effect of eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) on interleukin (IL)-8 production by CCD922SK cells, in unex-
posed cells ( ) and at 48 h after 100 mJ per cm2 UVB ( ) (n¼ 4). Oleic
acid (OA) and T/F (tetrahydrofuran (THF)/fetal calf serum (FCS))-treated

























Effect of n-3 PUFA on the TNFa-induced IL-8 in keratinocytes. The
effect of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
on interleukin (IL)-8 production by keratinocytes after stimulation with
20 ng per mL tumor necrosis factor (TNF)-a (n¼4). Oleic acid (OA) and
tetrahydrofuran (THF)/fetal calf serum (FCS) (T/F)-treated cells are con-
trols. po0.001 comparing TNF-a-treated cells with untreated cells,
þ þ þpo0.001 comparing oil-supplemented cells with THF/FCS-treat-
ed cells.
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IL-8 induces keratinocyte proliferation (Steude et al, 2002),
and is involved in angiogenesis and growth of a variety of
tumors, including melanoma (Huang et al, 2002; Watanabe
et al, 2002). Hence suppression of this cytokine is likely to
play a significant role in protection against UVB-induced
skin inflammation, and might also protect against longer-
term effects of UVB. Additionally, EPA inhibition of TNF-a-
induced IL-8 secretion by keratinocytes is a potential mech-
anism for protection by n-3 PUFA against a wider range of
inflammatory stimuli affecting the skin.
Our data is consistent with reports that keratinocytes are
an important source of IL-8 after UVB irradiation, providing
a powerful chemotactic stimulus by these cells (Strickland
et al, 1997). In addition, our studies suggest that direct UVB
stimulation of fibroblasts may make a contribution to the IL-
8 response. Although a smaller-fold increase in IL-8 was
seen following UVB exposure of fibroblasts than keratin-
ocytes, it is possible that UVB in vivo acts in synergy with
keratinocyte-derived TNF-a to augment the production of
IL-8 in the dermis (Larsen et al, 1989). IL-8 production is
highly induced when keratinocytes and fibroblasts are com-
bined to form skin equivalents, compared with cells grown
independently (Konstantinova et al, 1996), and a similarly
orchestrated IL-8 response could occur following UVB
stimulation. Fibroblasts are found in the skin in smaller
numbers than keratinocytes, but their dermal production of
chemokines may be of key importance in communication
with the skin’s vasculature. Secretion of IL-8 by fibroblasts
could thus act to enhance neutrophil migration into the de-
rmis after UVB exposure (Huber et al, 1991).
Regulation of IL-8 production is important, and n-3
PUFA, which are under-represented in the westernized diet
(Simopoulos, 1999), may provide a modulating mechanism
(Grimm et al, 2002). The chemokine is induced in epithelial
cells in response to a range of injurious stimuli, but contin-
ued upregulation may result in persistent inflammation and
tissue damage through prolonged neutrophil infiltration.
Higher IL-8 levels are associated with necrosis in burn
tissue (Lu et al, 2002), whereas in a lung-injury model,
immunoablation of the murine functional homolog of IL-8
significantly reduced tissue damage (Li et al, 2002). Admin-
istration of n-3 PUFA has been reported to be beneficial in a
range of inflammatory conditions (Ergas et al, 2002), and
may also be of value in the neutrophilic dermatoses. High
IL-8 levels are found in psoriasis (Nickoloff et al, 1991; Stic-
herling et al, 1999), and n-3 PUFA supplementation is re-
ported to reduce the cellular infiltrate (Soyland et al, 1993),
and to produce clinical benefit in some studies (Mayser
et al, 2002).
Our additional demonstration of reduced TNF-a-mediat-
ed effects by n-3 PUFA implies a wider range of anti-in-
flammatory properties for these agents, which may occur
through autocrine and other roles of this cytokine. This is
consistent with a report of up to 90% reduction of TNF-a
production in circulating mononuclear cells in patients with
rheumatoid arthritis taking n-3 PUFA, in tandem with clinical
improvement (James et al, 2000). In cultured keratinocytes
supplemented with EPA, however, Pupe et al (2002), ob-
served superinduction of UVB-induced TNF-a, in associa-
tion with suppression of UVB-induced IL-6. This finding,
which is consistent with observations of reciprocity of IL-6
and TNF-a in skin (Nishimura et al, 2000), requires further
examination.
In this work, the two major n-3 PUFA, i.e., EPA and DHA,
were found to be similar in potency in their anti-inflamma-
tory properties in skin cells, with respect to suppression of
both UVB- and TNF-a-induced IL-8 levels. In other situa-
tions, their relative potencies in suppressing inflammatory
events can vary, with, e.g., EPA4DHA with respect to IL-6
secretion in certain cells (Khalfoun et al, 1997). We found,
however, DHA supplementation of keratinocytes to also
significantly increase their EPA content, a phenomenon that
may be explained by retroconversion of DHA to EPA
(Vidgren et al, 1997). We also observed that in non-supple-
mented cells, UVB exposure tended to increase the amount
of cellular EPA and DHA (Table I). When cellular EPA content
was, however, increased after EPA supplementation, EPA
content fell after UVB, and the same pattern was seen with
DHA after DHA supplementation. We speculate that en-
hanced n-3 PUFA cell membrane content is mirrored by
enhanced availability of the free forms, and that both may
contribute to their anti-inflammatory properties in skin cells.
There are number of ways n-3 PUFA might modulate
UVB-induced production of IL-8. The highly unsaturated FA
can increase membrane fluidity up to a factor of 2 in cell
culture studies (Stubbs and Smith, 1984). Their effects on
membrane fluidity result in modification of a range of signal
transduction events (Merrill and Schroeder, 1993), and
could eventuate in altered cytokine production. Modulation
of oxidative stress by n-3 PUFA is another potential mech-
anism. Production of IL-8 is normally activated via NFkB
(Kunsch and Rosen, 1993), a redox sensitive transcription
factor (Rahman et al, 2002, 2003). Both UVB and TNF-a
activate NFkB; this activation can be inhibited with antioxi-
dants (Saliou et al, 1999; Rahman et al, 2003). Antioxidants
inhibit the production of IL-8 in association with a reduced
activation of NFkB (DeForge et al, 1992, 1993). The unstable
n-3 PUFA could have a similar effect by acting as a buffer,
quenching reactive oxygen species and protecting other
cellular structures from oxidative damage (van den Berg
et al, 1991; Rhodes et al, 1994). Furthermore, the n-6 PUFA
arachidonic acid (AA) is reported to be a direct activator of
NFkB, whereas EPA is not (Camandola et al, 1996). Hence
n-3 PUFA supplementation may conceivably reduce the
expression of NFkB-induced proteins including IL-8.
Supplementation with n-3 PUFA also results in the gen-
eration of 3-series prostanoids and reduced release of
PGE2 (Rhodes et al, 1995; Pupe et al, 2002). The n-3 PUFA
compete with AA for their phospholipase-mediated release
from membranes (Punnonen et al, 1987), and for metabo-
lism of the free FA by cyclooxygenase and lipoxygenase
(Lands, 1992). Synthesis of a range of less inflammatory
eicosanoids could thus contribute to downregulation of the
skin inflammatory response. In addition to reducing the
sunburn response, n-3 PUFA supplements protect against
rash provocation in polymorphic light eruption, in associa-
tion with a lowered skin PGE2 (Rhodes et al, 1995). Sup-
pression of PGE2 may contribute to the effects of n-3 PUFA
on IL-8 secretion. It has been reported that PGE2 increases
IL-8 production by post-translational mechanisms involving
stabilization of mRNA (Yu and Chadee, 1998). Further, PGE2
enhances IL-8 production by IL-1-stimulated human
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synovial fibroblasts (Agro et al, 1996). PGE2 does not, how-
ever, appear to directly stimulate IL-8 release in normal
human keratinocytes (Pernet et al, 1999), indicating scope
for involvement of the PGE2-independent mechanisms
discussed above in EPA- and DHA-suppression of IL-8
production.
In conclusion, we have demonstrated that EPA and DHA
reduce basal and UVB-induced IL-8 secretion by keratin-
ocytes and fibroblasts in vitro, and that these n-3 PUFA are
also capable of suppressing TNF-a-induced IL-8 secretion
in keratinocytes. Since IL-8 is a powerful chemoattractant
with important roles in UVB-induced inflammation and more
broadly in skin inflammation, these effects are likely to be
important in the protection conveyed by n-3 PUFA.
Materials and Methods
Cell culture CCD922SK fibroblasts (derived from normal human
breast skin of a 22-y-old female donor, American Type Culture
Collection, No. CRL 1828, Maryland) and HaCaT keratinocytes
(derived from the periphery of a melanoma on the back of a 62-y-
old male donor, considered immortal but not tumorigenic, obtained
from Dr Petra Boukamp, German Cancer Research Centre, Hei-
delberg, Germany, Boukamp et al, 1988) were cultured in DMEM
medium containing 10% FCS, 2 mM glutamine and 40 U per mL
penicillin and 40 mg per mL streptomycin.
Supplementation of FA to cells Twenty-four hours prior to ex-
perimental use, serum-containing medium was aspirated from
sub-confluent cells; the cells were washed twice with PBS and re-
immersed in defined serum-free media, AIMV (GibcoBRL Life
Technologies, Paisley, Scotland) containing 2 mM Glutamine. 5 mL
of free FA: OA, 18:1n-9 (  95% purity; Sigma, Poole, UK), EPA,
20:5n-3 and DHA, 22:6n-3 (  90% purity; gifts from Novel Lipids
Group, Unilever Research Laboratories, Colworth House, UK),
were dissolved in 235 mL of FCS. The mixture was vortexed thor-
oughly to ensure complete immersion of the oil before adding 10
mL of THF such that the final mixture consisted of 94%/4%/2%
FCS/THF/FA (vol/vol/vol). Stock solutions were diluted with 96%/
4% FCS/THF (vol/vol) to make 5 mM solutions of sub-stock. This
was diluted 1:100 with serum-free culture media and supplement-
ed to cells, providing a final dietary oil concentration of 50 mM. Cell
cultures were supplemented with FA for 4.5 days before UVB-ex-
posure. THF/FCS and OA-treated cells were controls for the stud-
ies. Absorption spectra of the FA showed UVB was not directly
absorbed by the oils (data not shown).
UVB exposure A fluorescent tube broadband UVB source was
used (Philips TL12; emission 270–400 nm; peak 311 nm; 61%
UVB, 32% UVA, 7% UVC (ultraviolet-C)). The UVC was filtered out
by tissue culture plastic. The irradiance (mW per cm2) of the lamps
was measured using an IL 1400A radiometer calibrated for use
with this light source (Able Instruments Ltd., Reading UK) and irra-
diation time was varied to provide doses of 25 to 100 mJ per cm2
UVB. Prior to irradiation, cells were washed twice and re-immersed
in PBS. Post-UVB, cells were re-immersed in culture media and
incubated for 48 h prior to experimental use.
Cell viability and protein analysis Cell viability was determined
by the trypan blue exclusion assay. UVB had no effect on HaCaT
cell viability at doses of 25–75 mJ per cm2; after 100 mJ per cm2
there was a decrease to 86.7%, po0.05. Fibroblast cell number
was unchanged after 25 mJ per cm2 and reduced to 50.1, 52.5 and
44.3% after 50, 75, and 100 mJ per cm2 UVB, respectively,
po0.05. Cell viability was not significantly altered by supplemen-
tation with any of the FA. Protein content, determined spectro-
photometrically by the Bicinchonic acid method (Smith et al, 1985),
was used to standardize IL-8 measurements, except for the dose–
response studies, which were standardized to cell number.
FA analysis Cellular FA content was analyzed by gas chroma-
tography (Perkin-Elmer 8500 GC System Beaconsfield, UK). Lipid
was extracted from cells using chloroform: methanol: 0.9% aque-
ous NaCl, 2:1:0.9 (vol/vol/vol), with a 20:1 (vol/vol) solvent to cel-
lular extract ratio. Butylated hydroxytoluene was added as an
antioxidant at a final concentration of 0.005%. FA methyl esters
(FAME) were produced by acid-catalyzed methylation and analy-
zed on a low-resolution, non-polar capillary column (Thames
Restick Ltd., Saunderton, UK) using 0.2 mL injection volumes, or a
high-resolution, polar capillary column (Chrompack Middleburg,
The Netherlands), using 0.5 mL injection volumes with split ratios
adjusted for optimum column loading. Purified oils of known com-
position were used as internal standards for identification. The
serum-free medium (AIMV) and FCS were profiled to ensure they
were not sources of FA.
IL-8 measurement Supernatants were harvested 4.5 days after
dietary oil supplementation and at 24, 48, and 72 h post-irradiation.
IL-8 was quantified by ELISA. Monoclonal and biotinylated anti-
human IL-8 antibodies (R&D Systems, Abingdon, UK) produced an
assay with typical sensitivity of 2.8 pg per mL. Recombinant IL-8
standards ranged from 7.8 to 1000 pg per mL.
Cytokine stimulation of cell culture Recombinant human TNF-a
(R&D Systems) was added to cultured keratinocytes at concen-
tration of 20 ng per mL for 48 h.
Statistical analysis Data are expressed as the mean  SEM and
analyzed for significance using one-way ANOVA and Bonferroni’s
modified t test at the 95% confidence interval.
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